首页> 外文期刊>Medicine. >Association between salivary amylase enzyme activity and obesity in Saudi Arabia
【24h】

Association between salivary amylase enzyme activity and obesity in Saudi Arabia

机译:沙特阿拉伯唾液淀粉酶活性与肥胖之间的关系

获取原文
       

摘要

Obesity is a significant public health concern that predisposes individuals to a high risk of premature mortality. Previous studies also reported that low serum concentrations of AMY1 have been associated with obesity . The aimed of the study to assess the relationship between salivary amylase (AMY1) activity and body mass index (BMI) in Saudi male and female adults in Riyadh. This study included a total of 200 (100 individuals who were overweight and obese and 100 who had normal body weight [control individuals]) Saudi participants aged 20 to 50 years old. They were recruited from physical fitness clubs and were school employees in Riyadh City. The dietary food intake was assessed using a 24-hour dietary recall. The activity of the AMY1 was measured using a microplate fluorescence reader. A significant ( P ≤ .05) increase was observed in the incidence of hypertension, dyslipidemia, diabetes mellitus (DM), and family history of overweight and obesity in overweight and obese individuals than in the control individuals, and these were in parallel to the significant increase in weight, waist circumference (WC), hip circumference (HC), systolic blood pressure (SBP), diastolic blood pressure (DBP), and BMI. A significant ( P ≤ .05) increase was also observed in the carbohydrate and total fat dietary intake of overweight and obese individuals in relation to the respective dietary reference intake (DRI) values. AMY1 activity was significantly lower than the reference values in the overweight and obese group. Furthermore, AMY1 activity was significantly ( P ≤ .05) reverse with weight, WC, HC, and BMI in both males and females in the overweight and obese group. In conclusion, the Saudi overweight and obese population seems to be at risk of low AMY1, which correlates with their obesity .
机译:肥胖是一项重大的公共卫生问题,使个人容易罹患过早死亡的高风险。先前的研究还报道了AMY1的低血清浓度与肥胖有关。该研究的目的是评估利雅得沙特男性和女性成年人唾液淀粉酶(AMY1)活性与体重指数(BMI)之间的关系。这项研究包括了200名年龄在20至50岁之间的沙特参与者(100名超重和肥胖的人和100名体重正常的人[对照组])。他们是从健身俱乐部招募的,是利雅得市的学校雇员。使用24小时饮食回想评估饮食中的食物摄入量。使用微孔板荧光读取器测量AMY1的活性。与对照组相比,超重和肥胖人群的高血压,血脂异常,糖尿病(DM)以及超重和肥胖家族史的发生率显着增加(P≤.05),与对照组和对照组的发病率平行。体重,腰围(WC),臀围(HC),收缩压(SBP),舒张压(DBP)和BMI显着增加。与各自的饮食参考摄入量(DRI)值相比,超重和肥胖个体的碳水化合物和总脂肪饮食摄入量也显着增加(P≤.05)。超重和肥胖组的AMY1活性明显低于参考值。此外,超重和肥胖组的男性和女性的体重,WC,HC和BMI均显着逆转AMY1活性(P≤0.05)。总之,沙特超重和肥胖人群似乎处于低AMY1的风险中,这与他们的肥胖症有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号